Urilin 40 mg/ml syrup Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

urilin 40 mg/ml syrup

dechra regulatory b.v. - phenylpropanolaminhydrochlorid - syrup - 40 mg/ml

Intuniv Den Europæiske Union - dansk - EMA (European Medicines Agency)

intuniv

takeda pharmaceuticals international ag ireland branch - guanfacinhydrochlorid - attention deficit disorder med hyperaktivitet - antiadrenergic agents, centrally acting, antihypertensives, - intuniv is indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children and adolescents 6 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective. intuniv skal bruges som en del af et omfattende adhd behandling program, typisk, herunder psykologiske, pædagogiske og sociale foranstaltninger.